Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain.

One of the challenges in treating central nervous system (CNS) disorders with biomolecules is achieving local delivery while minimizing invasiveness. For the treatment of stroke, stimulation of endogenous neural stem/progenitor cells (NSPCs) by growth factors is a promising strategy for tissue regeneration. Epidermal growth factor (EGF) enhances proliferation of endogenous NSPCs in the subventricular zone (SVZ) when delivered directly to the ventricles of the brain; however, this strategy is highly invasive. We designed a biomaterials-based strategy to deliver molecules directly to the brain without tissue damage. EGF or poly(ethylene glycol)-modified EGF (PEG-EGF) was dispersed in a hyaluronan and methylcellulose (HAMC) hydrogel and placed epi-cortically on both uninjured and stroke-injured mouse brains. PEG-modification decreased the rate of EGF degradation by proteases, leading to a significant increase in protein accumulation at greater tissue depths than previously shown. Consequently, EGF and PEG-EGF increased NSPC proliferation in uninjured and stroke-injured brains; and in stroke-injured brains, PEG-EGF significantly increased NSPC stimulation. Our epi-cortical delivery system is a minimally-invasive method for local delivery to the brain, providing a new paradigm for local delivery to the brain.

[1]  Daniel A. Lim,et al.  Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain , 1999, Cell.

[2]  R. Dempsey,et al.  Growth factors, stem cells, and stroke. , 2008, Neurosurgical focus.

[3]  Charles Nicholson,et al.  Diffusion and related transport mechanisms in brain tissue , 2001 .

[4]  D. Corbett,et al.  Transport of epidermal growth factor in the stroke-injured brain. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Christopher Gregg,et al.  Aging Results in Reduced Epidermal Growth Factor Receptor Signaling, Diminished Olfactory Neurogenesis, and Deficits in Fine Olfactory Discrimination , 2004, The Journal of Neuroscience.

[6]  E. Drapeau,et al.  Brain micro-ecologies: neural stem cell niches in the adult mammalian brain , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[7]  Charles Tator,et al.  Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery system. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[8]  S. Kernie,et al.  Subventricular zone neural stem cells remodel the brain following traumatic injury in adult mice. , 2004, Journal of neurotrauma.

[9]  Arturo Alvarez-Buylla,et al.  EGF Converts Transit-Amplifying Neurogenic Precursors in the Adult Brain into Multipotent Stem Cells , 2002, Neuron.

[10]  M. Shoichet,et al.  An injectable drug delivery platform for sustained combination therapy. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[11]  James W. Rowland,et al.  Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury. , 2008, Neurosurgical focus.

[12]  Bryan Kolb,et al.  Growth Factor-Stimulated Generation of New Cortical Tissue and Functional Recovery after Stroke Damage to the Motor Cortex of Rats , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  G. Paliouras,et al.  Aging of the subventricular zone neural stem cell niche: evidence for quiescence-associated changes between early and mid-adulthood , 2011, Neuroscience.

[14]  Kelly A. Tennant,et al.  Sensorimotor behavioral effects of endothelin-1 induced small cortical infarcts in C57BL/6 mice , 2009, Journal of Neuroscience Methods.

[15]  P. Tomasik,et al.  Novel biodegradable blend matrices for controlled drug release. , 2008, Journal of pharmaceutical sciences.

[16]  Deepali Mathur.  Proliferation in the human ipsilateral subventricular zone after ischemic stroke , 2010, Annals of Neurosciences.

[17]  J. V. Alstine,et al.  PEG-proteins: Reaction engineering and separation issues , 2006 .

[18]  R. Lonser,et al.  Image-guided convection-enhanced delivery of muscimol to the primate brain. , 2010, Journal of neurosurgery.

[19]  M. Moskowitz,et al.  EGF amplifies the replacement of parvalbumin-expressing striatal interneurons after ischemia. , 2003, The Journal of clinical investigation.

[20]  Adalberto Pessoa,et al.  Effect of polyethylene glycol on the thermal stability of green fluorescent protein , 2009, Biotechnology progress.

[21]  R. Felling,et al.  Enhanced neurogenesis following stroke , 2003, Journal of neuroscience research.

[22]  K. Nave,et al.  Epidermal growth factor does not cross the blood-brain barrier , 2004, Cell and Tissue Research.

[23]  A. Boer,et al.  Strategies to Improve Drug Delivery Across the Blood-Brain Barrier , 2007, Clinical pharmacokinetics.

[24]  P. Bath,et al.  Colony Stimulating Factors (Blood Growth Factors) Are Promising but Unproven for Treating Stroke , 2007 .

[25]  Lin Xie,et al.  Evidence for stroke-induced neurogenesis in the human brain , 2006, Proceedings of the National Academy of Sciences.

[26]  W. Mark Saltzman,et al.  Drugs released from polymers: diffusion and elimination in brain tissue , 1991 .

[27]  R. North,et al.  Implantable pumps for drug delivery to the brain , 1995, Journal of Neuro-Oncology.

[28]  E. Lo,et al.  Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinases , 2002, Journal of neuroscience research.

[29]  W. Berthold,et al.  Polyethylene glycol-conjugated pharmaceutical proteins , 1998 .

[30]  W. Mark Saltzman,et al.  Transport and elimination of recombinant human NGF during long-term delivery to the brain , 1996, Brain Research.

[31]  F. Yu,et al.  Immunosuppression promotes endogenous neural stem and progenitor cell migration and tissue regeneration after ischemic injury , 2011, Experimental Neurology.

[32]  W. Saltzman,et al.  Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  W Singer,et al.  Disruption of experience-dependent synaptic modifications in striate cortex by infusion of an NMDA receptor antagonist , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  A. Mangoni,et al.  Stroke, dementia, and drug delivery. , 2003, British journal of clinical pharmacology.

[35]  W. Mark Saltzman,et al.  Intracranial Delivery of Recombinant Nerve Growth Factor: Release Kinetics and Protein Distribution for Three Delivery Systems , 1999, Pharmaceutical Research.

[36]  M. Paradiso,et al.  Effects of intracortical infusion of 6-hydroxydopamine on the response of kitten visual cortex to monocular deprivation , 1983, Experimental Brain Research.

[37]  Charles H Tator,et al.  Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. , 2006, Biomaterials.

[38]  B. Moore,et al.  Proteins of the Brain Extracellular Fluid: Evidence for Release of S‐100 Protein , 1984, Journal of neurochemistry.

[39]  Effects of implantation of Alzet 1007D osmotic minipumps upon 2-deoxyglucose uptake in the cerebral cortex of mice. , 1993, Acta neurobiologiae experimentalis.